Hydralazine-isosorbide dinitrate in chronic heart failure with reduced ejection fraction: the H-HeFT trial

Lars Køber, Kim Wadt Skak-Hansen, Anders Hostrup Larsen, Søren Vraa, Morten Schou, Dan Eik Høfsten, Jens Refsgaard, Flemming Steffensen, Christian Hassager, Erik Parner, Jacob Møller, Hans Eiskjær, Hans Erik Bøtker, Kristine Serup-Hansen, Jette Sandberg Madsen, Søren Lund Kristensen, Mikael Kjær Poulsen, Claus Holst-Hansen, Malene Hollingdal, Jens Dahlgaard Hove, Anders Barasa, Emil Wolsk, Nina Pernille Gardshodn Buch, Niels Eske Bruun, Morten Bøttcher, Karen Dodt, Vibeke Brogaard, Gitte Nielsen, Henrik Ryde, Kirsten Vilain Mikkelsen, Yongzhong Wang, Esben Hjort Madsen, Monica Petronela Poenaru, Ilan Raymond, Kiomars Mahboubi, Morten Petersen, Niels Tønder, Gunnar Gislason, Søren Mellemkjær, Finn Gustafsson, Henrik Wiggers

Open source

DOI: 10.1093/eurheartj/ehag773
Published: 2026-11-04
Container: European Heart Journal
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag773,
  title = {Hydralazine-isosorbide dinitrate in chronic heart failure with reduced ejection fraction: the H-HeFT trial},
  author = {Lars Køber and Kim Wadt Skak-Hansen and Anders Hostrup Larsen and Søren Vraa and Morten Schou and Dan Eik Høfsten and Jens Refsgaard and Flemming Steffensen and Christian Hassager and Erik Parner and Jacob Møller and Hans Eiskjær and Hans Erik Bøtker and Kristine Serup-Hansen and Jette Sandberg Madsen and Søren Lund Kristensen and Mikael Kjær Poulsen and Claus Holst-Hansen and Malene Hollingdal and Jens Dahlgaard Hove and Anders Barasa and Emil Wolsk and Nina Pernille Gardshodn Buch and Niels Eske Bruun and Morten Bøttcher and Karen Dodt and Vibeke Brogaard and Gitte Nielsen and Henrik Ryde and Kirsten Vilain Mikkelsen and Yongzhong Wang and Esben Hjort Madsen and Monica Petronela Poenaru and Ilan Raymond and Kiomars Mahboubi and Morten Petersen and Niels Tønder and Gunnar Gislason and Søren Mellemkjær and Finn Gustafsson and Henrik Wiggers},
  year = {2026},
  journal = {European Heart Journal},
  doi = {10.1093/eurheartj/ehag773},
  url = {https://doi.org/10.1093/eurheartj/ehag773}
}

RIS

TY  - JOUR
TI  - Hydralazine-isosorbide dinitrate in chronic heart failure with reduced ejection fraction: the H-HeFT trial
AU  - Lars Køber
AU  - Kim Wadt Skak-Hansen
AU  - Anders Hostrup Larsen
AU  - Søren Vraa
AU  - Morten Schou
AU  - Dan Eik Høfsten
AU  - Jens Refsgaard
AU  - Flemming Steffensen
AU  - Christian Hassager
AU  - Erik Parner
AU  - Jacob Møller
AU  - Hans Eiskjær
AU  - Hans Erik Bøtker
AU  - Kristine Serup-Hansen
AU  - Jette Sandberg Madsen
AU  - Søren Lund Kristensen
AU  - Mikael Kjær Poulsen
AU  - Claus Holst-Hansen
AU  - Malene Hollingdal
AU  - Jens Dahlgaard Hove
AU  - Anders Barasa
AU  - Emil Wolsk
AU  - Nina Pernille Gardshodn Buch
AU  - Niels Eske Bruun
AU  - Morten Bøttcher
AU  - Karen Dodt
AU  - Vibeke Brogaard
AU  - Gitte Nielsen
AU  - Henrik Ryde
AU  - Kirsten Vilain Mikkelsen
AU  - Yongzhong Wang
AU  - Esben Hjort Madsen
AU  - Monica Petronela Poenaru
AU  - Ilan Raymond
AU  - Kiomars Mahboubi
AU  - Morten Petersen
AU  - Niels Tønder
AU  - Gunnar Gislason
AU  - Søren Mellemkjær
AU  - Finn Gustafsson
AU  - Henrik Wiggers
PY  - 2026
JO  - European Heart Journal
DO  - 10.1093/eurheartj/ehag773
UR  - https://doi.org/10.1093/eurheartj/ehag773
ER  -

APA

Køber, L., Skak-Hansen, K. W., Larsen, A. H., Vraa, S., Schou, M., Høfsten, D. E., Refsgaard, J., Steffensen, F., Hassager, C., Parner, E., Møller, J., Eiskjær, H., Bøtker, H. E., Serup-Hansen, K., Madsen, J. S., Kristensen, S. L., Poulsen, M. K., Holst-Hansen, C., Hollingdal, M., Hove, J. D., Barasa, A., Wolsk, E., Buch, N. P. G., Bruun, N. E., Bøttcher, M., Dodt, K., Brogaard, V., Nielsen, G., Ryde, H., Mikkelsen, K. V., Wang, Y., Madsen, E. H., Poenaru, M. P., Raymond, I., Mahboubi, K., Petersen, M., Tønder, N., Gislason, G., Mellemkjær, S., Gustafsson, F., & Wiggers, H. (2026). Hydralazine-isosorbide dinitrate in chronic heart failure with reduced ejection fraction: the H-HeFT trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehag773

Source records

crossref · retrieved 2026-11-10T13:24:26.504Z